<!DOCTYPE html>

<html lang="en">
<head>
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
	<meta name="viewport" content="width=device-width, initial-scale=1">
	<title></title>
	<link rel="stylesheet" href="css/as.css" type="text/css" />
	<link rel="stylesheet" href="css/animate.css" type="text/css" />
	<script type="text/javascript" src="js/base.js"></script>
	<script type="text/javascript" charset="utf-8">		
		var ANIMATION = [];		
	</script>   
</head>
<body class="popup-2-1">
<div id="popup"> 
<img src="images/as-01-popup-01.jpg" width="839" height="367" alt="Baseline Values"> 
<div class="copy1">*QD or BID dosing was based on regulatory approval for naïve patients; switch from capsule to tablet (meltrex) was made according to local regulatory approval<br>and drug availability. DRV/RTV, darunavir/ritonavir; KALETRA, lopinavir/ritonavir; TDF, tenofovir; FTC, emtricitabine.
</div>
</div>



</body>

</html>